Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 121 of 151

  1. Sintilimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anti-PD-1 Antibody

    phase 2 small molecule active

    1 trial

  2. Sintilimab

    The First People's Hospital of Lianyungang

    Ovarian Clear Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  3. Sintilimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Neoplasms

    phase 2 small molecule active

    1 trial

  4. Sintilimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  5. Sintilimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Renal Cell Carcinoma

    phase 2 small molecule active

    1 trial

  6. Sintilimab

    The First People's Hospital of Lianyungang

    Multiple Primary Lung Cancer

    phase 2 small molecule active

    1 trial

  7. Sintilimab

    The First People's Hospital of Lianyungang

    Small Cell Lung Cancer Limited Stage

    phase 2 small molecule active

    1 trial

  8. Sintilimab

    The First People's Hospital of Lianyungang

    Carcinoma

    phase 2 mab active

    1 trial

  9. Sintilimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small Cell Lung Cancer Stage III

    phase 2 small molecule active

    1 trial

  10. Sintilimab

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  11. Sintilimab

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma (NPC)

    phase 2 small molecule active

    1 trial

  12. Sintilimab (approved)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma (HCC)

    phase 2 small molecule active

    1 trial

  13. Sintilimab Combined with Platinum-containing Chemotherapy

    The First People's Hospital of Lianyungang

    Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  14. Sintilimab in combination with Multimodality Radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 2 small molecule active

    1 trial

  15. Sintilimab injection plus Inlyta treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Renal Cell

    phase 2 small molecule active

    1 trial

  16. Sintilimab with Interleukin-2+CAPOX

    The First People's Hospital of Lianyungang

    Locally Advanced Rectal Adenocarcinoma

    phase 2 small molecule completed

    1 trial

  17. Sintilimab,nab-paclitaxel and tegio

    The First People's Hospital of Lianyungang

    Gastric Cancer

    phase 2 small molecule active

    1 trial

  18. Sirolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Plastic Bronchitis

    phase 2 small molecule active

    1 trial

  19. Sirolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Kaposiform Hemangioendothelioma

    phase 2 small molecule active

    1 trial

  20. Sirolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hemangioendothelioma

    phase 2 small molecule active

    1 trial

  21. Sirolimus

    Ultragenyx UK Limited

    Anemia, Aplastic

    phase 2 small molecule active

    1 trial

  22. Sirolimus 0.5 mg

    Ultragenyx UK Limited

    Beta-Thalassemia

    phase 2 small molecule active

    2 trials

  23. Sitravatinib

    BeiGene

    Carcinoma, Hepatocellular

    phase 2 small molecule completed

    1 trial

  24. Skyrizi 600 mg concentrate for solution for infusion

    Disc Medicine

    Inflammatory Bowel Disease (IBD)

    phase 2 small molecule active

    1 trial

  25. Sm-EDTMP

    Jazz Pharmaceuticals Ireland Limited

    Metastatic Osteosarcoma

    phase 2 small molecule terminated

    1 trial

  26. Smoking research cigarettes with e-cigarette

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    phase 2 small molecule completed

    1 trial

  27. Sobi.PEGCET-201

    Swedish Orphan Biovitrum AB (publ)

    Transplant-associated Thrombotic Microangiopathy (TA TMA)

    phase 2 other active

    1 trial

  28. Sodium Benzoate

    Ultragenyx UK Limited

    Amino Acid Metabolism, Inborn Errors

    phase 2 small molecule completed

    1 trial

  29. Sodium Chloride 0.9% w/v Intravenous Infusion...

    Disc Medicine

    aneurysmal subarachnoid hemorrhage

    phase 2 small molecule active

    1 trial

  30. Sodium Cridanimod

    Xenetic Biosciences

    Endometrial Cancer

    phase 2 small molecule terminated

    1 trial

  31. Sodium Oxybate

    Jazz Pharmaceuticals Ireland Limited

    Essential Tremor

    phase 2 small molecule completed

    1 trial

  32. Sodium Oxybate

    Jazz Pharmaceuticals Ireland Limited

    Schizophrenia

    phase 2 small molecule completed

    1 trial

  33. Sodium Oxybate

    Jazz Pharmaceuticals Ireland Limited

    Alternating Hemiplegia of Childhood

    phase 2 small molecule completed

    1 trial

  34. Sodium Phenylbutyrate

    Ultragenyx UK Limited

    Argininosuccinic Aciduria

    phase 2 small molecule completed

    1 trial

  35. Sodium chloride Fresenius Kabi 0 for Cerebral Autosomal Dominant Art…

    Lacuna Pharma Pty Ltd

    Cerebral Autosomal Dominant Arteriopathy with subcortical Infarcts and Leukoencephalopathy (CADASIL)

    phase 2 small molecule active

    1 trial

  36. Sodium phenylbutyrate

    ZEVRA THERAPEUTICS, INC.

    Medium-chain Acyl-CoA Dehydrogenase Deficiency

    phase 2 small molecule active

    1 trial

  37. Sodium stibogluconate

    The First People's Hospital of Lianyungang

    Myelodysplastic Syndromes

    phase 2 small molecule active

    1 trial

  38. Sofosbuvir

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis C, Chronic

    phase 2 small molecule completed

    1 trial

  39. Softisan 378, Cannabidiol

    Disc Medicine

    psychological disorders: PTSD; Anxiety disorders

    phase 2 small molecule active

    1 trial

  40. Solabegron

    GlaxoSmithKline

    Overactive Bladder

    phase 2 small molecule completed

    1 trial

  41. Solriamfetol

    Axsome Therapeutics

    Multiple Sclerosis

    phase 2 small molecule active

    1 trial

  42. Solution for injection in pre-filled syringe

    Alphapharm Pty Ltd

    Short Bowel Syndrome-associated Intestinal Failure (SBS-IF)

    phase 2 small molecule active

    1 trial

  43. Sonelokimab

    MoonLake Immunotherapeutics

    axial spondyloarthritis

    phase 2 small molecule active

    1 trial

  44. Sonelokimab

    MoonLake Immunotherapeutics

    Palmoplantar Pustulosis

    phase 2 small molecule active

    1 trial

  45. Sonelokimab (M1095)

    MoonLake Immunotherapeutics

    Hidradenitis Suppurativa

    phase 2 small molecule completed

    1 trial

  46. Sonodynamic therapy(SDT)

    The First People's Hospital of Lianyungang

    Peripheral Arterial Disease

    phase 2 other terminated

    1 trial

  47. Sonrotoclax

    BEONE MEDICINES AUS PTY LTD

    Waldenstrom Macroglobulinemia

    phase 2 small molecule active

    1 trial

  48. Sonrotoclax

    BEONE MEDICINES AUS PTY LTD

    Relapsed/Refractory Multiple Myeloma

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.